Related Experiment Video

Updated: May 29, 2026

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

[Blueprint for the development of remyelination medicines for multiple sclerosis]

Jin Nakahara1

  • 1Center for Integrated Medical Research & Department of Neurology, Keio University School of Medicine, Tokyo, Japan.

Rinsho Shinkeigaku = Clinical Neurology
|September 17, 2011
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

Related Experiment Videos

Last Updated: May 29, 2026

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

Articles linked to this work by shared authors, journal, and citation graph.

The characterization of Parkinson's disease related pain based on the classification system: The severity of neuropathic pain and the clinical profile of nociplastic pain.

Clinical parkinsonism & related disorders·2026

Clinical and autonomic correlates of chronic Sialorrhea in Parkinson's disease: a questionnaire-based study with cluster analysis of autonomic and dysphagia burden.

Clinical parkinsonism & related disorders·2026

Differential impact of smoking on intracerebral haemorrhage based on cerebral microbleed status: a case-control study.

BMJ open·2026

Impact of Cerebral Small Vessel Disease on Functional Decline: Bleeding With Antithrombotic Therapy 2 Study.

Stroke·2026

Discrepancies in symptom concerns and burden from the perspectives of parkinson's disease patients, caregivers, and physicians.

Frontiers in neurology·2026

Iba1 deficiency impairs microglial synaptic remodeling and neuronal survival after axonal injury.

Journal of neuroinflammation·2026

[Clinical practice and research of chronic inflammatory demyelinating polyneuropathy: current status and future].

Rinsho shinkeigaku = Clinical neurology·2026

[Tibial nerve somatosensory evoked potentials localize the responsible level in tandem spinal stenosis: a case report].

Rinsho shinkeigaku = Clinical neurology·2026

[Cervical cancer metastasis to the lumbosacral spinal root: a case report].

Rinsho shinkeigaku = Clinical neurology·2026

[Ketogenic diet reintroduction in an adult patient with glucose transporter type 1 deficiency syndrome].

Rinsho shinkeigaku = Clinical neurology·2026

[Practice of obstetric medicine in neurological disorders: towards evidence-based shared decision-making (SDM)].

Rinsho shinkeigaku = Clinical neurology·2026

[Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome with eclampsia, posterior reversible encephalopathy syndrome (PRES), and severe intracerebral hemorrhage in the early postpartum period: a case report].

Rinsho shinkeigaku = Clinical neurology·2026

Correction: Induced pluripotent stem cells as natural biofactories for exosomes carrying miR-199b-5p in the treatment of spinal cord injury.

Frontiers in pharmacology·2026

Repetitive transcranial magnetic stimulation: advances for psychiatric disorders.

Frontiers in psychiatry·2026

Advances in the clinical application of stellate ganglion block for non-pain indications.

Frontiers in medicine·2026

Correction: In-network multidisciplinary digital care improves outcomes in medicare advantage members with musculoskeletal diagnoses.

Frontiers in digital health·2026

Adaptation of the Yield-Scaling Factor to Reduce Target Yield Deviation and Donation Time in Pathogen-Reduced Apheresis Platelet Collections Using the Sysmex XN1000 Blood Bank Mode.

Annals of laboratory medicine·2026

The Trodden and Untrodden Path: Mentorship, Innovation, and Leadership in Dermatology.

Dermatologic clinics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us